PatternsRadar
Sign in

RUBICONRubicon Research Limited

NSEASM Stage I
1,718.70INR-3.60 (-0.21%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹28,451 CrMarket cap
87.6P/E (TTM)
65.8%Delivery

Filings & corporate actions

5 results filed
CSV
Next results · Q3 FY27
Expected 3 Feb 2027 – 28 Feb 2027
Estimate: filed 34–59 days after quarter end, last 5 times
Dividend
₹1.50 per share · last 7 Aug 2026
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone-4.7%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026-1.5%NSE
  • 14 AugresultsResults · Q1 FY27 · consolidated and standalone+11.1%NSE
  • 7 AugdividendDividend · ₹1.50 per share+1.3%
  • 18 JulshareholdingShareholding · 30 Jun 2026+5.0%NSE
  • 29 MayresultsResults · Q4 FY26 · consolidated and standalone+16.5%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-0.7%NSE
  • 3 FebresultsResults · Q3 FY26 · consolidated and standalone+7.2%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-0.7%NSE

Reaction to results · all yearsrose on day 0 in 4 of 5 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026-4.7%-3.6%—3.5×
Q1 FY2714 Aug 2026+11.1%+9.7%+12.1%14.4×
Q4 FY2629 May 2026+16.5%+17.5%+39.5%23.4×
Q3 FY263 Feb 2026+7.2%+8.1%+4.1%8.1×
Q2 FY2613 Nov 2025+9.1%+3.6%-2.8%—
Average+7.8%+7.1%+13.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+39.9%
Profit YoY+68.0%
Interest cost YoY—
Revenue QoQ+7.9%
Profit QoQ+6.7%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open1,722.30
Day range1,691.20 – 1,755.00
52-week range609.25 – 1,899.00
From 52w high-9.5%
RSI (14)57.5
ATR (14)70.53
Volume2.42L
Avg volume (20D)1.82L
Rel volume1.33×
Volatility (1Y)42.9%
Turnover₹41.5Cr
Traded value (NSE)₹41.5Cr
VWAP1,713.97
SMA 50 / 2001,639.55 / 1,279.59
Price band20%

Delivery percentage

Latest · 20 Nov 202665.8%
20-day avg50.1%
1-year avg46.3%
Percentile (own history)96th
Range10.1–81.7%
Sessions272

Over the last 20 sessions RUBICON settled 50.1% of its traded quantity, which is above average for an NSE equity. Its one-year average is 46.3%, so recent sessions are running 3.7 points higher than usual. The latest session ranks higher than 96% of the 272 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.09%
Dividend, trailing 12M₹1.50
Paid every year for1 yr
Shareholders38.0K · -12.1% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy86 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.21%+2.47%+19.64%-2.38%+77.35%+140.78%

Valuation

Market cap₹28,451 Cr
Market cap (NSE)₹28,450 Cr
Free-float cap₹13,870 Cr
P/E (TTM)87.6
P/E (NSE)87.8
EPS (TTM)19.62
P/B20.1
Net margin (TTM)15.5%
Other income / PBT3.4%
ROE31.5%
Debt / equity0.28
Shares outstanding16.55Cr
Listed16 Oct 2025

Ownership

Promoter51.25%
Promoter Δ QoQ-8.51 pp
Public48.75%
FII9.01%
DII15.72%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)475.5513.9534.3576.4
YoY chg———+39.9%
Net profit (₹ Cr)72.876.884.890.4
YoY chg———+67.9%
Net margin15.3%14.9%15.9%15.7%
EPS4.414.605.085.41

Shareholding over time

By quarter

30 Sept 2026 · promoter 51.25% · public 48.75%
15 Oct 2025: promoter 59.99%31 Dec 2025: promoter 59.99%31 Mar 2026: promoter 59.86%30 Jun 2026: promoter 59.76%30 Sept 2026: promoter 51.25%
2025-102026-09
  • Promoter
  • Public and others
Promoter
51.25%
Public
48.75%
Promoter change
-8.51 pp
Filed
19 Oct 2026
FII
9.01%
DII
15.72%
Promoter pledged
0.00%

Who the public is

Mutual funds
13.78%

+6.55 pp QoQ

Insurance
0.16%

-0.02 pp QoQ

FPI
9.01%

+1.49 pp QoQ

Retail ≤ ₹2L
3.34%

+0.18 pp QoQ

HNI > ₹2L
0.56%

+0.26 pp QoQ

NRI
1.76%

+0.02 pp QoQ

Bodies corporate
0.38%

+0.21 pp QoQ

Shareholders
38,018

-12.1% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
General Atlantic Singapore Rr Pte LtdPromoter · Corporate27.34%
Shivanand Shankar Mankekar HufOther13.51%
Surabhi Parag SanchetiPromoter · Individual7.91%
Sumant PilgaonkarPromoter · Individual7.89%
Kotak Midcap FundMutual fund4.09%
Pratibha Sudhir PilgaonkarPromoter · Individual3.89%
Sudhir D PilgaonkarPromoter · Individual3.89%
Hdfc Trustee Company Ltd. A/C Hdfc Balanced Advantage FundMutual fund3.50%
Amansa Investments LtdCorporate3.12%
Motilal Oswal Small Cap FundMutual fund1.39%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 7 Aug 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹1.50₹1.50
Ex-dateRecord dateDeclaredAdjusted
7 Aug 2026—₹1.50₹1.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
−₹2,325.0Cr
Promoters net, 90d
−₹2,325.0Cr
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
27
24 open-market of the newest 27
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
15 Sept 2026GIRISH SUBRAMANIAM IYEREmployeeSell3.0K₹54.9L1,829.8051.2K → 48.2K0.03%-0.00 pp7(2)told 15 Sept 2026
15 Sept 2026GIRISH SUBRAMANIAM IYEREmployeeSell1.3K₹23.2L1,788.4852.5K → 51.2K0.03%-0.00 pp7(2)told 15 Sept 2026
15 Sept 2026GIRISH SUBRAMANIAM IYEREmployeeSell1.5K₹27.3L1,821.0054.0K → 52.5K0.03%-0.00 pp7(2)told 11 Sept 2026
15 Sept 2026GIRISH SUBRAMANIAM IYEREmployeeSell1.0K₹18.1L1,809.9055.0K → 54.0K0.03%-0.00 pp7(2)told 10 Sept 2026
4 Sept 2026Vinayak SawantEmployeeSell1.1K₹20.3L1,843.548.4K → 7.3K0.00%0.00 pp7(2)told 2 Sept 2026
28 Aug 2026General Atlantic Singapore RR Pte LtdPromoterSell1.39Cr₹2,299.6Cr1,660.005.91Cr → 4.53Cr27.34%-8.37 pp7(2)told 26 Aug 2026
28 Aug 2026General Atlantic Singapore RR Pte LtdPromoterSell1.47L₹25.4Cr1,729.825.93Cr → 5.91Cr35.70%-0.09 pp7(2)told 26 Aug 2026
25 Aug 2026Sanjay RenapurkarEmployeeSell2.0K₹35.8L1,790.542.0K → 00.00%7(2)told 21 Aug 2026
25 Aug 2026Sanjay RenapurkarEmployeeSell4.0K₹70.1L1,752.506.0K → 2.0K0.00%0.00 pp7(2)told 21 Aug 2026
21 Aug 2026Sarabjit SinghEmployeeSell35.0K~₹6.3Cr1,804.102.82L → 2.47L0.15%-0.02 pp7(2)told 19 Aug 2026
1 Jul 2026Girish Subramaniam IyerEmployeeSell10.0K~₹1.4Cr1,402.9041.8K → 31.8K0.02%-0.01 pp7(2)told 30 Jun 2026
30 Jun 2026Prakash ChandranEmployeeSell20.0K₹2.8Cr1,408.5730.0K → 10.0K0.01%-0.02 pp7(2)told 30 Jun 2026
23 Jun 2026DINESH BHASKAR RAJADHYAXEmployeeSell2.3K~₹31.2L1,368.3032.3K → 30.0K0.02%-0.00 pp7(2)told 19 Jun 2026
17 Jun 2026Rajendra MhaskeEmployeeSell3.0K~₹38.6L1,285.3025.1K → 22.1K0.01%-0.00 pp7(2)told 15 Jun 2026
17 Jun 2026Rajendra MhaskeEmployeeBuy16~₹19,0101,188.1025.1K → 25.1K0.02%+0.00 pp7(2)told 15 Jun 2026
17 Jun 2026Rajendra MhaskeEmployeeSell1.0K~₹11.9L1,188.1026.1K → 25.1K0.02%-0.00 pp7(2)told 15 Jun 2026
17 Jun 2026Rajendra MhaskeEmployeeSell2.0K~₹23.6L1,181.4028.1K → 26.1K0.02%-0.00 pp7(2)told 15 Jun 2026
17 Jun 2026Rajendra MhaskeEmployeeSell50~₹64,9101,298.2028.1K → 28.1K0.02%-0.00 pp7(2)told 15 Jun 2026
17 Jun 2026Vinayak SawantEmployeeSell780~₹10.1L1,295.50787 → 70.00%0.00 pp7(2)told 15 Jun 2026
17 Jun 2026Vinayak SawantEmployeeSell1.4K~₹18.0L1,285.302.2K → 7870.00%0.00 pp7(2)told 15 Jun 2026
17 Jun 2026Vinayak SawantEmployeeSell600~₹7.1L1,188.102.8K → 2.2K0.00%0.00 pp7(2)told 12 Jun 2026
9 Jun 2026Rajendra MhaskeEmployeeSell2.0K~₹24.1L1,202.5030.1K → 28.1K0.02%-0.00 pp7(2)told 8 Jun 2026
9 Jun 2026Vinayak SawantEmployeeSell1.2K~₹14.7L1,202.504.0K → 2.8K0.00%0.00 pp7(2)told 8 Jun 2026
9 Jun 2026Sarabjit SinghEmployeeSell15.1K~₹1.9Cr1,272.002.97L → 2.82L0.17%-0.01 pp7(2)told 5 Jun 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 26 Aug 2026

CSV
5 of 5 deals
By year
DateDealClientQuantityPriceValue
26 Aug 2026Buy · block, also bulkARANDA INVESTMENTS PTE. LTD.8.43L1,660.00₹140.0Cr
26 Aug 2026Sell · block, also bulkGENERAL ATLANTIC SINGAPORE RR PTE LTD8.43L1,660.00₹140.0Cr
16 Oct 2025Buy · bulkNOMURA FUNDS IRELAND PLC NOMURA FUNDS IRELAND INDIA EQUITY FUND16.50L616.31₹101.7Cr
16 Oct 2025Sell · bulkJUNOMONETA FINSOL PRIVATE LIMITED11.87L615.52₹73.0Cr
16 Oct 2025Buy · bulkJUNOMONETA FINSOL PRIVATE LIMITED11.87L615.34₹73.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • Long-term ASM · Stage I · since 18 Aug 2026 — Long-term Additional Surveillance Measure: after a sustained unusual move, trades carry a higher margin and, at later stages, settle trade-for-trade.
  • P/E > 50 (4 quarters) · since 28 Apr 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations412.0475.5513.9534.3576.4
Other income0.73.82.65.72.3
Total income412.7479.3516.5540.0578.7
Total expenses341.0388.7417.8429.6461.8
└ Finance costs11.49.810.49.311.4
└ Depreciation11.911.612.315.118.0
Profit before tax71.790.698.7110.4116.9
Tax expense17.917.821.925.626.5
Net profit53.972.876.884.890.4
EPS3.494.464.665.135.47
Net margin13.07%15.31%14.94%15.87%15.69%
PBT margin17.40%19.05%19.20%20.66%20.29%
Tax rate24.90%19.64%22.19%23.19%22.66%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY26FY26H1 FY27
Total assets1,782.32,326.72,760.8
Current assets1,221.81,681.81,747.2
└ Cash & equivalents137.2185.7209.0
└ Other bank balances14.2160.471.9
└ Current investments0.00.01.6
└ Trade receivables344.9508.7577.7
└ Inventories630.2729.0790.4
Total equity647.41,288.81,431.1
└ Attributable to owners647.41,288.81,416.3
└ Non-controlling interest0.00.014.7
└ Share capital15.416.516.6
Borrowings516.6259.4398.4
└ Current346.4116.3209.9
└ Non-current170.3143.0188.5
Trade payables241.4377.5368.0
Current liabilities893.2835.9953.0
Total liabilities1,134.91,037.91,329.7
Net debt365.2(86.6)115.9
Debt / equity0.800.200.28
Current ratio1.372.011.83

Cash flow, year to date

 H1 FY26FY26H1 FY27
Operating cash flow104.5205.098.9
└ Capex(165.1)(229.2)(94.9)
Free cash flow(60.6)(24.1)3.9
Investing cash flow(164.0)(409.7)(171.9)
Financing cash flow91.1283.187.6
└ Dividends paid(0.3)(0.3)(24.8)
└ Buybacks0.00.00.0
Net change in cash32.380.715.0

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

RUBICON at a glance

  • RUBICON closed at ₹1,718.7 on 20 Nov 2026, -0.21% on the day, +140.8% over one year, 9.5% below its 52-week high of ₹1,899.
  • Delivery was 65.8% of traded quantity on 20 Nov 2026, the 96th percentile of its own 272 sessions with a reading (20-session average 50.1%, 1-year average 46.3%).
  • Market capitalisation is ₹28,451 crore at a trailing P/E of 87.6 (trailing EPS ₹19.62).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹576 crore (+39.9% year on year), net profit ₹90 crore (+67.9%); the price moved -4.7% on the first session after.
  • Promoters held 51.25% at 30 Sept 2026, down 8.51 percentage points on the previous filing.
  • Q3 FY27 results are expected between 3 Feb 2027 and 28 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE506V01022
SeriesEQ
Listed16 Oct 2025
IPO price485.00 · band Rs.461 to Rs.485
IPO listing16 Oct 2025
NSE market cap · 17 Nov 2026₹27,875 Cr
Free-float market cap (NSE)₹5,982 Cr
Shares outstanding (NSE)16.55Cr
History from16 Oct 2025
Sessions272
Turnover rank#579

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.